Q1. What is the current size of the antihypertensive drugs market?

A1. The antihypertensive drugs market stands at USD 26.69 billion in 2025 and is projected to reach USD 31.69 billion by 2030. Read More

Q2. Which drug class leads global sales?

A2. Angiotensin II Receptor Blockers hold the largest share at 31.43% of 2024 revenue, thanks to strong efficacy and tolerability. Read More

Q3. Which region will grow fastest through 2030?

A3. Asia-Pacific is expected to post the highest CAGR at 5.67%, driven by rising hypertension prevalence and expanding healthcare access. Read More

Q4. How are fixed-dose combinations influencing the market?

A4. Triple- and dual-agent tablets improve adherence and have gained favorable reimbursement, boosting their uptake and lifting overall market value. Read More

Q5. What impact will patent expiries have between 2025–2027?

A5. Patent cliffs for major ARBs and CCBs will intensify generic competition, likely depressing branded prices but widening patient access. Read More

Global Anti-hypertensive Drugs Companies

This report lists the top Global Anti-hypertensive Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Anti-hypertensive Drugs industry.